Top 20 of Hyperlipidemias

Article title # Publications/# Citations

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

2001: Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;

2385

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1972: DSFredrickson; WTFriedewald; RILevy;

2041

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

2002: National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);

1513

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

2004: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents;

522

Obesity and metabolic syndrome in circadian Clock mutant mice.

2005: JBass; AEaston; RHEckel; GIvanova; DRJensen; CJoshu; AKohsaka; ALaposky; ... ELin; SLosee-Olson; EMcDearmon; JSTakahashi; FWTurek;

357

Cardiovascular morbidity and mortality associated with the metabolic syndrome.

2001: PAlmgren; BForsén; LGroop; BIsomaa; KLahti; MNissen; MRTaskinen; TTuomi;

348

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

2003: PGaede; GVJensen; NLarsen; HHParving; OPedersen; PVedel;

337

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

2004: Swedish Obese Subjects Study Scientific Group; CBouchard; BCarlsson; SDahlgren; BLarsson; AKLindroos; KNarbro; MPeltonen; ... CDSjöström; LSjöström; MSullivan; JTorgerson; HWedel;

293

The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

1972: DWBilheimer; SEisenberg; RILevy;

240

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

1991: RADeFronzo; EFerrannini;

228

The mechanisms of action of PPARs.

2002: JBerger; DEMoller;

213

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.

1993: DJBarker; PMClark; CHFall; CNHales; COsmond; KPhipps;

213

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

2002: JABeckman; MACreager; PLibby;

197

The PPARs: from orphan receptors to drug discovery.

2000: PJBrown; BRHenke; DDSternbach; TMWillson;

185

Clinical inertia.

2001: CSBarnes; WTBranch; CBCook; JPDoyle; IMEl-Kebbi; DLGallina; CDMiller; LSPhillips; DCZiemer;

179

Statins and the risk of dementia.

2000: DADrachman; HJick; SSJick; SSeshadri; GLZornberg;

174

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

1998: SBurton; ACarr; DJChisholm; DACooper; JFreund; MLaw; KSamaras;

166

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

2004: SSFranklin; TVKamath; GJL'Italien; SMalik; JRPio; GRWilliams; NDWong;

165

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

2007: European Association for the Study of Diabetes (EASD); Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); MBartnik; MBertrand; JBetteridge; JJBlanc; ABudaj; JCamm; ... BCharbonnel; FCosentino; MJde Boer; VDean; JDeckers; JWDeckers; KDickstein; EErdmann; EFerrannini; AFlyvbjerg; HGohlke; IGraham; BJonsson; JRJuanatey; MLaakso; JLekakis; PLindgren; KMalmberg; KMcGregor; MMetra; PFMonteiro; JMorais; JÖstergren; AOsterspey; KParhofer; SPriori; SGPriori; KPyörälä; QQiao; IRaz; LRydén; GSchernthaner; EStandl; MStramba-Badiale; JTamargo; IThrainsdottir; JTuomilehto; GVan den Berghe; IVanhorebeek; MVolpe; DWood; JLZamorano;

164

Impact of aortic stiffness on survival in end-stage renal disease.

1999: JBlacher; APGuérin; GMLondon; SJMarchais; BPannier; MESafar;

162